Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
153 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- John Muir Medical Center-Concord Campus
Concord, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Gynecologic Oncology Associates-Newport Beach
Newport Beach, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Rocky Mountain Gynecologic Oncology Pc
Englewood, Colorado, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Northeast Georgia Medical Center-Gainesville
Gainesville, Georgia, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Memorial Medical Center
Springfield, Illinois, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Mcfarland Clinic Pc - Ames
Ames, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa-Wide Oncology Research Coalition Ncorp
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- Cancer Center of Kansas - Chanute
Chanute, Kansas, United States
- Cancer Center of Kansas - Dodge City
Dodge City, Kansas, United States
- Cancer Center of Kansas - El Dorado
El Dorado, Kansas, United States
- Cancer Center of Kansas - Fort Scott
Fort Scott, Kansas, United States
- Cancer Center of Kansas-Independence
Independence, Kansas, United States
- Cancer Center of Kansas-Kingman
Kingman, Kansas, United States
- Cancer Center of Kansas-Liberal
Liberal, Kansas, United States
- Cancer Center of Kansas - Newton
Newton, Kansas, United States
- Cancer Center of Kansas - Parsons
Parsons, Kansas, United States
- Cancer Center of Kansas - Pratt
Pratt, Kansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Apr 2012
- Primary completion
- 27 Jan 2018
- Completion
- 27 Jan 2018
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 52
- Registry id
- NCT01540565
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.